Crookston K P, Webb D J, Lamarre J, Gonias S L
Department of Biochemistry, University of Virginia Health Sciences Center, Charlottesville 22908.
Biochem J. 1993 Jul 15;293 ( Pt 2)(Pt 2):443-50. doi: 10.1042/bj2930443.
alpha 2-Macroglobulin (alpha 2M) undergoes a major conformational change when reacting with proteinases or primary amines. This conformational change has been referred to as the 'slow' to 'fast' transformation based on the increase in alpha 2M mobility shown by non-denaturing PAGE. Previous studies demonstrated that many cytokines, including transforming growth factor beta 1 (TGF-beta 1) and interleukin-1 beta, bind preferentially or exclusively to alpha 2M which has undergone conformational change. In this study, we demonstrate that platelet-derived growth factor-BB (PDGF-BB) also binds preferentially to conformationally transformed alpha 2M (alpha 2M-methylamine, alpha 2M-trypsin) in vitro. Purified 125I-PDGF-BB-alpha 2M-methylamine complex cleared rapidly from the circulation of mice via the alpha 2M receptor/low-density-lipoprotein-receptor-related protein (alpha 2M-R/LRP). In order to determine whether PDGF-BB or TGF-beta 1 binds to native alpha 2M, we defined the native conformation by lack of interaction with alpha 2M-R/LRP instead of electrophoretic mobility. 125I-PDGF-BB was incubated with 4.3 microM native alpha 2M and 0.47 microM alpha 2M-methylamine. The 125I-PDGF-BB distributed evenly between slow-form and fast-form alpha 2M without shifting the electrophoretic mobility of either species. When the mixed preparation was injected intravenously in mice, 125I-PDGF-BB-fast-form-alpha 2M cleared rapidly and selectively from the circulation; 125I-PDGF-BB which was bound to slow-form alpha 2M was stable in the blood (apparently not recognized by alpha 2M-R/LRP). Therefore, while conformationally transformed alpha 2M binds PDGF-BB preferentially in vitro, non-alpha 2M-R/LRP-recognized alpha 2M binds PDGF-BB as well. Binding of 125I-PDGF-BB and 125I-TGF-beta 1 to alpha 2M was demonstrated in vivo by injecting the free growth factors intravenously into mice. Plasma samples which were subjected to non-denaturing PAGE and autoradiography demonstrated binding of both growth factors exclusively to the slow-form of alpha 2M. Therefore, under normal physiological conditions, native alpha 2M (non-alpha 2M-R/LRP-recognized) is the primary form of the proteinase inhibitor functioning as a carrier of PDGF-BB and TGF-beta 1 in the blood.
α2-巨球蛋白(α2M)在与蛋白酶或伯胺反应时会发生重大构象变化。基于非变性聚丙烯酰胺凝胶电泳(PAGE)显示的α2M迁移率增加,这种构象变化被称为“慢”到“快”转变。先前的研究表明,许多细胞因子,包括转化生长因子β1(TGF-β1)和白细胞介素-1β,优先或仅与经历构象变化的α2M结合。在本研究中,我们证明血小板衍生生长因子-BB(PDGF-BB)在体外也优先与构象转化的α2M(α2M-甲胺、α2M-胰蛋白酶)结合。纯化的125I-PDGF-BB-α2M-甲胺复合物通过α2M受体/低密度脂蛋白受体相关蛋白(α2M-R/LRP)从小鼠循环中迅速清除。为了确定PDGF-BB或TGF-β1是否与天然α2M结合,我们通过缺乏与α2M-R/LRP的相互作用而不是电泳迁移率来定义天然构象。将125I-PDGF-BB与4.3微摩尔天然α2M和0.47微摩尔α2M-甲胺一起孵育。125I-PDGF-BB在慢形式和快形式的α2M之间均匀分布,而不会改变任何一种形式的电泳迁移率。当将混合制剂静脉注射到小鼠体内时,125I-PDGF-BB-快形式-α2M从循环中迅速且选择性地清除;与慢形式α2M结合的125I-PDGF-BB在血液中稳定(显然未被α2M-R/LRP识别)。因此,虽然构象转化的α2M在体外优先结合PDGF-BB,但未被α2M-R/LRP识别的α2M也结合PDGF-BB。通过将游离生长因子静脉注射到小鼠体内,在体内证明了125I-PDGF-BB和125I-TGF-β1与α2M的结合。经过非变性PAGE和放射自显影的血浆样品显示,两种生长因子都仅与慢形式的α2M结合。因此,在正常生理条件下,天然α2M(未被α2M-R/LRP识别)是蛋白酶抑制剂的主要形式,在血液中作为PDGF-BB和TGF-β1的载体发挥作用。